nodes	percent_of_prediction	percent_of_DWPC	metapath
Telaprevir—ALB—chronic obstructive pulmonary disease	0.387	1	CbGaD
Telaprevir—ALB—Prednisone—chronic obstructive pulmonary disease	0.0462	0.179	CbGbCtD
Telaprevir—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0455	0.177	CbGbCtD
Telaprevir—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0307	0.119	CbGbCtD
Telaprevir—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0293	0.114	CbGbCtD
Telaprevir—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0261	0.101	CbGbCtD
Telaprevir—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0256	0.0994	CbGbCtD
Telaprevir—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0241	0.0939	CbGbCtD
Telaprevir—CTSK—leg—chronic obstructive pulmonary disease	0.0178	0.216	CbGeAlD
Telaprevir—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0153	0.0596	CbGbCtD
Telaprevir—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0145	0.0562	CbGbCtD
Telaprevir—CMA1—respiratory system—chronic obstructive pulmonary disease	0.00686	0.0834	CbGeAlD
Telaprevir—CMA1—connective tissue—chronic obstructive pulmonary disease	0.00604	0.0734	CbGeAlD
Telaprevir—CMA1—smooth muscle tissue—chronic obstructive pulmonary disease	0.00552	0.0671	CbGeAlD
Telaprevir—CTSK—respiratory system—chronic obstructive pulmonary disease	0.00442	0.0537	CbGeAlD
Telaprevir—CTSK—connective tissue—chronic obstructive pulmonary disease	0.00389	0.0473	CbGeAlD
Telaprevir—CTSS—respiratory system—chronic obstructive pulmonary disease	0.00387	0.0471	CbGeAlD
Telaprevir—CMA1—lung—chronic obstructive pulmonary disease	0.00364	0.0443	CbGeAlD
Telaprevir—CTSK—bronchus—chronic obstructive pulmonary disease	0.00364	0.0442	CbGeAlD
Telaprevir—CTSK—smooth muscle tissue—chronic obstructive pulmonary disease	0.00356	0.0433	CbGeAlD
Telaprevir—Endocrine disorder—Roflumilast—chronic obstructive pulmonary disease	0.00355	0.0285	CcSEcCtD
Telaprevir—CTSS—connective tissue—chronic obstructive pulmonary disease	0.00341	0.0414	CbGeAlD
Telaprevir—CTSK—trachea—chronic obstructive pulmonary disease	0.00327	0.0397	CbGeAlD
Telaprevir—CTSS—bronchus—chronic obstructive pulmonary disease	0.00319	0.0387	CbGeAlD
Telaprevir—CTSS—smooth muscle tissue—chronic obstructive pulmonary disease	0.00312	0.0379	CbGeAlD
Telaprevir—Oral candidiasis—Tiotropium—chronic obstructive pulmonary disease	0.00291	0.0234	CcSEcCtD
Telaprevir—CTSS—trachea—chronic obstructive pulmonary disease	0.00286	0.0348	CbGeAlD
Telaprevir—Oral candidiasis—Arformoterol—chronic obstructive pulmonary disease	0.00235	0.0189	CcSEcCtD
Telaprevir—Oral candidiasis—Formoterol—chronic obstructive pulmonary disease	0.00235	0.0189	CcSEcCtD
Telaprevir—CTSK—lung—chronic obstructive pulmonary disease	0.00235	0.0285	CbGeAlD
Telaprevir—Renal failure acute—Roflumilast—chronic obstructive pulmonary disease	0.00231	0.0186	CcSEcCtD
Telaprevir—Hyperuricaemia—Aminophylline—chronic obstructive pulmonary disease	0.00212	0.017	CcSEcCtD
Telaprevir—CTSS—lung—chronic obstructive pulmonary disease	0.00206	0.025	CbGeAlD
Telaprevir—Blood uric acid increased—Aminophylline—chronic obstructive pulmonary disease	0.002	0.016	CcSEcCtD
Telaprevir—Candida infection—Tiotropium—chronic obstructive pulmonary disease	0.00177	0.0142	CcSEcCtD
Telaprevir—Rectal haemorrhage—Formoterol—chronic obstructive pulmonary disease	0.00165	0.0133	CcSEcCtD
Telaprevir—Rectal haemorrhage—Arformoterol—chronic obstructive pulmonary disease	0.00165	0.0133	CcSEcCtD
Telaprevir—Infestation—Roflumilast—chronic obstructive pulmonary disease	0.00165	0.0132	CcSEcCtD
Telaprevir—Infestation NOS—Roflumilast—chronic obstructive pulmonary disease	0.00165	0.0132	CcSEcCtD
Telaprevir—Gout—Arformoterol—chronic obstructive pulmonary disease	0.0016	0.0128	CcSEcCtD
Telaprevir—Gout—Formoterol—chronic obstructive pulmonary disease	0.0016	0.0128	CcSEcCtD
Telaprevir—Hepatobiliary disease—Roflumilast—chronic obstructive pulmonary disease	0.00156	0.0125	CcSEcCtD
Telaprevir—Candida infection—Formoterol—chronic obstructive pulmonary disease	0.00143	0.0114	CcSEcCtD
Telaprevir—Candida infection—Arformoterol—chronic obstructive pulmonary disease	0.00143	0.0114	CcSEcCtD
Telaprevir—Hypokalaemia—Aminophylline—chronic obstructive pulmonary disease	0.0013	0.0104	CcSEcCtD
Telaprevir—Malnutrition—Roflumilast—chronic obstructive pulmonary disease	0.00129	0.0103	CcSEcCtD
Telaprevir—Dysgeusia—Roflumilast—chronic obstructive pulmonary disease	0.00126	0.0101	CcSEcCtD
Telaprevir—ORM1—lung—chronic obstructive pulmonary disease	0.00123	0.0149	CbGeAlD
Telaprevir—Eczema—Montelukast—chronic obstructive pulmonary disease	0.00118	0.00949	CcSEcCtD
Telaprevir—Lymphopenia—Prednisone—chronic obstructive pulmonary disease	0.00115	0.00922	CcSEcCtD
Telaprevir—Eczema—Salbutamol—chronic obstructive pulmonary disease	0.00114	0.00914	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Roflumilast—chronic obstructive pulmonary disease	0.00109	0.00873	CcSEcCtD
Telaprevir—Infection—Roflumilast—chronic obstructive pulmonary disease	0.00104	0.00837	CcSEcCtD
Telaprevir—Nervous system disorder—Roflumilast—chronic obstructive pulmonary disease	0.00103	0.00827	CcSEcCtD
Telaprevir—Skin disorder—Roflumilast—chronic obstructive pulmonary disease	0.00102	0.00819	CcSEcCtD
Telaprevir—Hypokalaemia—Formoterol—chronic obstructive pulmonary disease	0.000987	0.00792	CcSEcCtD
Telaprevir—Hypokalaemia—Arformoterol—chronic obstructive pulmonary disease	0.000987	0.00792	CcSEcCtD
Telaprevir—Toxic epidermal necrolysis—Montelukast—chronic obstructive pulmonary disease	0.000957	0.00768	CcSEcCtD
Telaprevir—Hypokalaemia—Salbutamol—chronic obstructive pulmonary disease	0.000932	0.00748	CcSEcCtD
Telaprevir—Urinary tract disorder—Tiotropium—chronic obstructive pulmonary disease	0.000918	0.00737	CcSEcCtD
Telaprevir—Hypothyroidism—Prednisone—chronic obstructive pulmonary disease	0.000916	0.00735	CcSEcCtD
Telaprevir—Oedema peripheral—Tiotropium—chronic obstructive pulmonary disease	0.000916	0.00735	CcSEcCtD
Telaprevir—Urethral disorder—Tiotropium—chronic obstructive pulmonary disease	0.000911	0.00731	CcSEcCtD
Telaprevir—Eosinophilia—Montelukast—chronic obstructive pulmonary disease	0.000909	0.0073	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.000907	0.00728	CcSEcCtD
Telaprevir—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.000906	0.00727	CcSEcCtD
Telaprevir—Eye disorder—Tiotropium—chronic obstructive pulmonary disease	0.000869	0.00697	CcSEcCtD
Telaprevir—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.000834	0.0067	CcSEcCtD
Telaprevir—Infestation NOS—Montelukast—chronic obstructive pulmonary disease	0.000819	0.00657	CcSEcCtD
Telaprevir—Infestation—Montelukast—chronic obstructive pulmonary disease	0.000819	0.00657	CcSEcCtD
Telaprevir—Stevens-Johnson syndrome—Montelukast—chronic obstructive pulmonary disease	0.000812	0.00651	CcSEcCtD
Telaprevir—Malnutrition—Tiotropium—chronic obstructive pulmonary disease	0.000809	0.00649	CcSEcCtD
Telaprevir—Hepatobiliary disease—Montelukast—chronic obstructive pulmonary disease	0.000774	0.00621	CcSEcCtD
Telaprevir—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000754	0.00605	CcSEcCtD
Telaprevir—Urinary tract disorder—Arformoterol—chronic obstructive pulmonary disease	0.000741	0.00595	CcSEcCtD
Telaprevir—Urinary tract disorder—Formoterol—chronic obstructive pulmonary disease	0.000741	0.00595	CcSEcCtD
Telaprevir—Oedema peripheral—Formoterol—chronic obstructive pulmonary disease	0.000739	0.00593	CcSEcCtD
Telaprevir—Oedema peripheral—Arformoterol—chronic obstructive pulmonary disease	0.000739	0.00593	CcSEcCtD
Telaprevir—Urethral disorder—Formoterol—chronic obstructive pulmonary disease	0.000736	0.0059	CcSEcCtD
Telaprevir—Urethral disorder—Arformoterol—chronic obstructive pulmonary disease	0.000736	0.0059	CcSEcCtD
Telaprevir—Syncope—Tiotropium—chronic obstructive pulmonary disease	0.000726	0.00582	CcSEcCtD
Telaprevir—Urinary tract disorder—Montelukast—chronic obstructive pulmonary disease	0.000726	0.00582	CcSEcCtD
Telaprevir—Urethral disorder—Montelukast—chronic obstructive pulmonary disease	0.00072	0.00578	CcSEcCtD
Telaprevir—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000719	0.00577	CcSEcCtD
Telaprevir—Loss of consciousness—Tiotropium—chronic obstructive pulmonary disease	0.000711	0.00571	CcSEcCtD
Telaprevir—Endocrine disorder—Prednisone—chronic obstructive pulmonary disease	0.000709	0.00569	CcSEcCtD
Telaprevir—Urinary tract disorder—Salbutamol—chronic obstructive pulmonary disease	0.0007	0.00561	CcSEcCtD
Telaprevir—Infection—Aminophylline—chronic obstructive pulmonary disease	0.000696	0.00558	CcSEcCtD
Telaprevir—Erythema multiforme—Montelukast—chronic obstructive pulmonary disease	0.000695	0.00558	CcSEcCtD
Telaprevir—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000695	0.00557	CcSEcCtD
Telaprevir—Urethral disorder—Salbutamol—chronic obstructive pulmonary disease	0.000695	0.00557	CcSEcCtD
Telaprevir—Shock—Aminophylline—chronic obstructive pulmonary disease	0.000689	0.00553	CcSEcCtD
Telaprevir—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.000687	0.00551	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.000684	0.00549	CcSEcCtD
Telaprevir—ABCB1—respiratory system—chronic obstructive pulmonary disease	0.000683	0.00831	CbGeAlD
Telaprevir—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000668	0.00536	CcSEcCtD
Telaprevir—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000662	0.00531	CcSEcCtD
Telaprevir—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000662	0.00531	CcSEcCtD
Telaprevir—Infection—Tiotropium—chronic obstructive pulmonary disease	0.000656	0.00527	CcSEcCtD
Telaprevir—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.000653	0.00524	CcSEcCtD
Telaprevir—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.000653	0.00524	CcSEcCtD
Telaprevir—Shock—Tiotropium—chronic obstructive pulmonary disease	0.00065	0.00521	CcSEcCtD
Telaprevir—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000648	0.0052	CcSEcCtD
Telaprevir—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.000642	0.00515	CcSEcCtD
Telaprevir—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.00064	0.00513	CcSEcCtD
Telaprevir—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.00064	0.00513	CcSEcCtD
Telaprevir—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000624	0.00501	CcSEcCtD
Telaprevir—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.000617	0.00495	CcSEcCtD
Telaprevir—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.000604	0.00485	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00057	0.00458	CcSEcCtD
Telaprevir—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000556	0.00447	CcSEcCtD
Telaprevir—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000553	0.00444	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000552	0.00443	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000552	0.00443	CcSEcCtD
Telaprevir—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000542	0.00435	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000541	0.00434	CcSEcCtD
Telaprevir—Infection—Formoterol—chronic obstructive pulmonary disease	0.00053	0.00425	CcSEcCtD
Telaprevir—Infection—Arformoterol—chronic obstructive pulmonary disease	0.00053	0.00425	CcSEcCtD
Telaprevir—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000525	0.00421	CcSEcCtD
Telaprevir—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000523	0.0042	CcSEcCtD
Telaprevir—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000523	0.0042	CcSEcCtD
Telaprevir—Infection—Montelukast—chronic obstructive pulmonary disease	0.000519	0.00416	CcSEcCtD
Telaprevir—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000518	0.00416	CcSEcCtD
Telaprevir—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000518	0.00416	CcSEcCtD
Telaprevir—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000512	0.00411	CcSEcCtD
Telaprevir—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000511	0.0041	CcSEcCtD
Telaprevir—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000507	0.00407	CcSEcCtD
Telaprevir—ABCB1—trachea—chronic obstructive pulmonary disease	0.000505	0.00614	CbGeAlD
Telaprevir—Infection—Salbutamol—chronic obstructive pulmonary disease	0.0005	0.00401	CcSEcCtD
Telaprevir—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000496	0.00398	CcSEcCtD
Telaprevir—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000495	0.00397	CcSEcCtD
Telaprevir—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000494	0.00396	CcSEcCtD
Telaprevir—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000489	0.00392	CcSEcCtD
Telaprevir—CTSK—Toll-Like Receptors Cascades—TLR4—chronic obstructive pulmonary disease	0.000484	0.00325	CbGpPWpGaD
Telaprevir—CMA1—Degradation of the extracellular matrix—MMP9—chronic obstructive pulmonary disease	0.000481	0.00323	CbGpPWpGaD
Telaprevir—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000479	0.00385	CcSEcCtD
Telaprevir—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000467	0.00375	CcSEcCtD
Telaprevir—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000463	0.00372	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00046	0.00369	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00046	0.00369	CcSEcCtD
Telaprevir—CTSS—Innate Immune System—LY96—chronic obstructive pulmonary disease	0.00046	0.00309	CbGpPWpGaD
Telaprevir—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00046	0.00369	CcSEcCtD
Telaprevir—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00046	0.00369	CcSEcCtD
Telaprevir—CTSS—Adaptive Immune System—RAPGEF3—chronic obstructive pulmonary disease	0.000454	0.00305	CbGpPWpGaD
Telaprevir—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000451	0.00362	CcSEcCtD
Telaprevir—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.00045	0.00361	CcSEcCtD
Telaprevir—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000445	0.00357	CcSEcCtD
Telaprevir—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000442	0.00354	CcSEcCtD
Telaprevir—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000441	0.00354	CcSEcCtD
Telaprevir—CTSS—Extracellular matrix organization—TGFB2—chronic obstructive pulmonary disease	0.00044	0.00295	CbGpPWpGaD
Telaprevir—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000437	0.00351	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000435	0.00349	CcSEcCtD
Telaprevir—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000434	0.00348	CcSEcCtD
Telaprevir—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00043	0.00288	CbGpPWpGaD
Telaprevir—CTSK—Degradation of the extracellular matrix—MMP9—chronic obstructive pulmonary disease	0.000429	0.00288	CbGpPWpGaD
Telaprevir—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000424	0.0034	CcSEcCtD
Telaprevir—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000424	0.0034	CcSEcCtD
Telaprevir—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00042	0.00337	CcSEcCtD
Telaprevir—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000417	0.00334	CcSEcCtD
Telaprevir—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000416	0.00334	CcSEcCtD
Telaprevir—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000416	0.00334	CcSEcCtD
Telaprevir—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000415	0.00333	CcSEcCtD
Telaprevir—ALB—Folate Metabolism—SOD3—chronic obstructive pulmonary disease	0.000406	0.00273	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000401	0.00269	CbGpPWpGaD
Telaprevir—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.0004	0.00321	CcSEcCtD
Telaprevir—CTSS—Toll-Like Receptors Cascades—TLR4—chronic obstructive pulmonary disease	0.000398	0.00267	CbGpPWpGaD
Telaprevir—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000392	0.00315	CcSEcCtD
Telaprevir—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.000388	0.00312	CcSEcCtD
Telaprevir—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000382	0.00307	CcSEcCtD
Telaprevir—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000382	0.00307	CcSEcCtD
Telaprevir—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000377	0.00303	CcSEcCtD
Telaprevir—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000377	0.00303	CcSEcCtD
Telaprevir—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000375	0.00301	CcSEcCtD
Telaprevir—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000374	0.00251	CbGpPWpGaD
Telaprevir—CTSS—Collagen formation—MMP9—chronic obstructive pulmonary disease	0.00037	0.00248	CbGpPWpGaD
Telaprevir—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000369	0.00296	CcSEcCtD
Telaprevir—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000365	0.00293	CcSEcCtD
Telaprevir—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000365	0.00293	CcSEcCtD
Telaprevir—ABCB1—lung—chronic obstructive pulmonary disease	0.000363	0.00441	CbGeAlD
Telaprevir—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000361	0.0029	CcSEcCtD
Telaprevir—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000357	0.00287	CcSEcCtD
Telaprevir—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000356	0.00286	CcSEcCtD
Telaprevir—CTSS—Degradation of the extracellular matrix—MMP9—chronic obstructive pulmonary disease	0.000353	0.00237	CbGpPWpGaD
Telaprevir—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000353	0.00283	CcSEcCtD
Telaprevir—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000353	0.00283	CcSEcCtD
Telaprevir—CMA1—Extracellular matrix organization—MMP1—chronic obstructive pulmonary disease	0.000347	0.00233	CbGpPWpGaD
Telaprevir—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000345	0.00277	CcSEcCtD
Telaprevir—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000344	0.00276	CcSEcCtD
Telaprevir—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00034	0.00228	CbGpPWpGaD
Telaprevir—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000339	0.00272	CcSEcCtD
Telaprevir—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000339	0.00272	CcSEcCtD
Telaprevir—Rash—Formoterol—chronic obstructive pulmonary disease	0.000336	0.0027	CcSEcCtD
Telaprevir—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000336	0.0027	CcSEcCtD
Telaprevir—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000336	0.00269	CcSEcCtD
Telaprevir—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000336	0.00269	CcSEcCtD
Telaprevir—ALB—Vitamin B12 Metabolism—MPO—chronic obstructive pulmonary disease	0.000335	0.00225	CbGpPWpGaD
Telaprevir—CTSK—Immune System—RAPGEF3—chronic obstructive pulmonary disease	0.000335	0.00224	CbGpPWpGaD
Telaprevir—CMA1—Signaling by SCF-KIT—MMP9—chronic obstructive pulmonary disease	0.000333	0.00223	CbGpPWpGaD
Telaprevir—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000333	0.00267	CcSEcCtD
Telaprevir—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000332	0.00266	CcSEcCtD
Telaprevir—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000332	0.00223	CbGpPWpGaD
Telaprevir—Rash—Montelukast—chronic obstructive pulmonary disease	0.000329	0.00264	CcSEcCtD
Telaprevir—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000329	0.00264	CcSEcCtD
Telaprevir—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000326	0.00218	CbGpPWpGaD
Telaprevir—CTSK—Immune System—LY96—chronic obstructive pulmonary disease	0.000325	0.00218	CbGpPWpGaD
Telaprevir—ALB—Selenium Micronutrient Network—SOD3—chronic obstructive pulmonary disease	0.000323	0.00217	CbGpPWpGaD
Telaprevir—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00032	0.00257	CcSEcCtD
Telaprevir—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000317	0.00255	CcSEcCtD
Telaprevir—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000317	0.00255	CcSEcCtD
Telaprevir—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000317	0.00254	CcSEcCtD
Telaprevir—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000317	0.00254	CcSEcCtD
Telaprevir—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000317	0.00254	CcSEcCtD
Telaprevir—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000312	0.0021	CbGpPWpGaD
Telaprevir—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000311	0.00249	CcSEcCtD
Telaprevir—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00031	0.00249	CcSEcCtD
Telaprevir—CTSK—Extracellular matrix organization—MMP1—chronic obstructive pulmonary disease	0.000309	0.00207	CbGpPWpGaD
Telaprevir—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000301	0.00202	CbGpPWpGaD
Telaprevir—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000299	0.0024	CcSEcCtD
Telaprevir—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000284	0.00228	CcSEcCtD
Telaprevir—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000276	0.00221	CcSEcCtD
Telaprevir—CTSS—Immune System—RAPGEF3—chronic obstructive pulmonary disease	0.000276	0.00185	CbGpPWpGaD
Telaprevir—ALB—Folate Metabolism—MPO—chronic obstructive pulmonary disease	0.000273	0.00183	CbGpPWpGaD
Telaprevir—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000271	0.00182	CbGpPWpGaD
Telaprevir—CMA1—Signaling by SCF-KIT—EGFR—chronic obstructive pulmonary disease	0.000269	0.00181	CbGpPWpGaD
Telaprevir—CTSS—Immune System—LY96—chronic obstructive pulmonary disease	0.000268	0.0018	CbGpPWpGaD
Telaprevir—CMA1—Extracellular matrix organization—SERPINE1—chronic obstructive pulmonary disease	0.000263	0.00177	CbGpPWpGaD
Telaprevir—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000261	0.00175	CbGpPWpGaD
Telaprevir—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000257	0.00206	CcSEcCtD
Telaprevir—CTSS—Extracellular matrix organization—MMP1—chronic obstructive pulmonary disease	0.000255	0.00171	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—TLR2—chronic obstructive pulmonary disease	0.000254	0.0017	CbGpPWpGaD
Telaprevir—CMA1—Metabolism of proteins—ACE—chronic obstructive pulmonary disease	0.000253	0.00169	CbGpPWpGaD
Telaprevir—ALB—Platelet degranulation—SERPINA1—chronic obstructive pulmonary disease	0.000248	0.00167	CbGpPWpGaD
Telaprevir—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000247	0.00166	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000243	0.00163	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—KL—chronic obstructive pulmonary disease	0.000239	0.0016	CbGpPWpGaD
Telaprevir—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000238	0.00191	CcSEcCtD
Telaprevir—ALB—Response to elevated platelet cytosolic Ca2+—SERPINA1—chronic obstructive pulmonary disease	0.000237	0.00159	CbGpPWpGaD
Telaprevir—CTSK—Extracellular matrix organization—SERPINE1—chronic obstructive pulmonary disease	0.000235	0.00157	CbGpPWpGaD
Telaprevir—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000231	0.00185	CcSEcCtD
Telaprevir—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000229	0.00184	CcSEcCtD
Telaprevir—CTSK—Adaptive Immune System—KL—chronic obstructive pulmonary disease	0.000229	0.00154	CbGpPWpGaD
Telaprevir—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000227	0.00152	CbGpPWpGaD
Telaprevir—CMA1—Metabolism of proteins—PLAUR—chronic obstructive pulmonary disease	0.000227	0.00152	CbGpPWpGaD
Telaprevir—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000226	0.00181	CcSEcCtD
Telaprevir—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000218	0.00146	CbGpPWpGaD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000217	0.00174	CcSEcCtD
Telaprevir—ALB—Selenium Micronutrient Network—MPO—chronic obstructive pulmonary disease	0.000217	0.00145	CbGpPWpGaD
Telaprevir—ALB—Platelet degranulation—TGFB2—chronic obstructive pulmonary disease	0.000215	0.00144	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—TLR2—chronic obstructive pulmonary disease	0.000209	0.0014	CbGpPWpGaD
Telaprevir—Infection—Prednisone—chronic obstructive pulmonary disease	0.000208	0.00167	CcSEcCtD
Telaprevir—ABCB1—Allograft Rejection—IL13—chronic obstructive pulmonary disease	0.000207	0.00139	CbGpPWpGaD
Telaprevir—CMA1—Signaling by SCF-KIT—IL6—chronic obstructive pulmonary disease	0.000207	0.00139	CbGpPWpGaD
Telaprevir—Shock—Prednisone—chronic obstructive pulmonary disease	0.000206	0.00166	CcSEcCtD
Telaprevir—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000206	0.00165	CcSEcCtD
Telaprevir—ALB—Response to elevated platelet cytosolic Ca2+—TGFB2—chronic obstructive pulmonary disease	0.000205	0.00138	CbGpPWpGaD
Telaprevir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000204	0.00137	CbGpPWpGaD
Telaprevir—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000204	0.00164	CcSEcCtD
Telaprevir—CMA1—Extracellular matrix organization—MMP9—chronic obstructive pulmonary disease	0.000202	0.00135	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—KL—chronic obstructive pulmonary disease	0.000196	0.00132	CbGpPWpGaD
Telaprevir—CTSS—Extracellular matrix organization—SERPINE1—chronic obstructive pulmonary disease	0.000193	0.0013	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—RAPGEF3—chronic obstructive pulmonary disease	0.000192	0.00129	CbGpPWpGaD
Telaprevir—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000191	0.00153	CcSEcCtD
Telaprevir—ABCB1—Allograft Rejection—IL17A—chronic obstructive pulmonary disease	0.000191	0.00128	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000189	0.00127	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—KL—chronic obstructive pulmonary disease	0.000189	0.00127	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—CD8A—chronic obstructive pulmonary disease	0.000185	0.00124	CbGpPWpGaD
Telaprevir—CTSK—Toll-Like Receptors Cascades—IL6—chronic obstructive pulmonary disease	0.000184	0.00124	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000184	0.00123	CbGpPWpGaD
Telaprevir—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000182	0.00146	CcSEcCtD
Telaprevir—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000182	0.00146	CcSEcCtD
Telaprevir—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000181	0.00145	CcSEcCtD
Telaprevir—CTSK—Extracellular matrix organization—MMP9—chronic obstructive pulmonary disease	0.00018	0.00121	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—ERBB3—chronic obstructive pulmonary disease	0.000179	0.0012	CbGpPWpGaD
Telaprevir—ALB—Vitamin B12 Metabolism—CRP—chronic obstructive pulmonary disease	0.000176	0.00118	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—ERBB3—chronic obstructive pulmonary disease	0.000172	0.00115	CbGpPWpGaD
Telaprevir—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000171	0.00138	CcSEcCtD
Telaprevir—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000167	0.00134	CcSEcCtD
Telaprevir—CMA1—Extracellular matrix organization—TGFB1—chronic obstructive pulmonary disease	0.000166	0.00112	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—CRP—chronic obstructive pulmonary disease	0.000163	0.0011	CbGpPWpGaD
Telaprevir—CMA1—Metabolism of proteins—MMP1—chronic obstructive pulmonary disease	0.000162	0.00109	CbGpPWpGaD
Telaprevir—ABCB1—HIF-1-alpha transcription factor network—HMOX1—chronic obstructive pulmonary disease	0.000161	0.00108	CbGpPWpGaD
Telaprevir—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00016	0.00108	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000158	0.00106	CbGpPWpGaD
Telaprevir—CMA1—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	0.000157	0.00105	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—TLR4—chronic obstructive pulmonary disease	0.000157	0.00105	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—CD8A—chronic obstructive pulmonary disease	0.000152	0.00102	CbGpPWpGaD
Telaprevir—CTSS—Toll-Like Receptors Cascades—IL6—chronic obstructive pulmonary disease	0.000152	0.00102	CbGpPWpGaD
Telaprevir—ABCB1—HIF-1-alpha transcription factor network—EDN1—chronic obstructive pulmonary disease	0.000151	0.00101	CbGpPWpGaD
Telaprevir—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000151	0.00121	CcSEcCtD
Telaprevir—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000148	0.00119	CcSEcCtD
Telaprevir—CMA1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000148	0.000995	CbGpPWpGaD
Telaprevir—CTSK—Extracellular matrix organization—TGFB1—chronic obstructive pulmonary disease	0.000148	0.000994	CbGpPWpGaD
Telaprevir—CTSS—Extracellular matrix organization—MMP9—chronic obstructive pulmonary disease	0.000148	0.000993	CbGpPWpGaD
Telaprevir—CTSK—Immune System—TLR2—chronic obstructive pulmonary disease	0.000148	0.000991	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—ERBB3—chronic obstructive pulmonary disease	0.000147	0.000988	CbGpPWpGaD
Telaprevir—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000144	0.00115	CcSEcCtD
Telaprevir—ALB—Folate Metabolism—CRP—chronic obstructive pulmonary disease	0.000144	0.000963	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—ERBB3—chronic obstructive pulmonary disease	0.000141	0.000949	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000141	0.000947	CbGpPWpGaD
Telaprevir—CTSK—Immune System—KL—chronic obstructive pulmonary disease	0.000139	0.000932	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000139	0.000931	CbGpPWpGaD
Telaprevir—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000139	0.00111	CcSEcCtD
Telaprevir—ALB—Vitamin B12 Metabolism—SERPINE1—chronic obstructive pulmonary disease	0.000135	0.000909	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—CRP—chronic obstructive pulmonary disease	0.000135	0.000903	CbGpPWpGaD
Telaprevir—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000133	0.00107	CcSEcCtD
Telaprevir—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000133	0.00089	CbGpPWpGaD
Telaprevir—Rash—Prednisone—chronic obstructive pulmonary disease	0.000132	0.00106	CcSEcCtD
Telaprevir—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000132	0.00106	CcSEcCtD
Telaprevir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.00013	0.00087	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—IL10—chronic obstructive pulmonary disease	0.00013	0.000869	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—TLR4—chronic obstructive pulmonary disease	0.000129	0.000866	CbGpPWpGaD
Telaprevir—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000128	0.000859	CbGpPWpGaD
Telaprevir—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000125	0.001	CcSEcCtD
Telaprevir—ABCB1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000124	0.00083	CbGpPWpGaD
Telaprevir—ABCB1—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	0.000123	0.000825	CbGpPWpGaD
Telaprevir—CTSS—Extracellular matrix organization—TGFB1—chronic obstructive pulmonary disease	0.000122	0.000818	CbGpPWpGaD
Telaprevir—CTSS—Immune System—TLR2—chronic obstructive pulmonary disease	0.000122	0.000816	CbGpPWpGaD
Telaprevir—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000117	0.000782	CbGpPWpGaD
Telaprevir—ABCB1—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	0.000115	0.000769	CbGpPWpGaD
Telaprevir—CTSS—Immune System—KL—chronic obstructive pulmonary disease	0.000114	0.000768	CbGpPWpGaD
Telaprevir—ALB—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	0.000114	0.000765	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	0.000113	0.000759	CbGpPWpGaD
Telaprevir—CTSK—Immune System—CD8A—chronic obstructive pulmonary disease	0.000112	0.000751	CbGpPWpGaD
Telaprevir—ALB—Folate Metabolism—SERPINE1—chronic obstructive pulmonary disease	0.00011	0.000739	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—SERPINA1—chronic obstructive pulmonary disease	0.00011	0.000739	CbGpPWpGaD
Telaprevir—ALB—Vitamin B12 Metabolism—IL1B—chronic obstructive pulmonary disease	0.00011	0.000738	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000108	0.000727	CbGpPWpGaD
Telaprevir—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000105	0.000706	CbGpPWpGaD
Telaprevir—CMA1—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	0.000104	0.000699	CbGpPWpGaD
Telaprevir—CTSK—Immune System—ERBB3—chronic obstructive pulmonary disease	0.000104	0.000699	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000101	0.000676	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	9.88e-05	0.000663	CbGpPWpGaD
Telaprevir—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	9.66e-05	0.000648	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—TGFB2—chronic obstructive pulmonary disease	9.55e-05	0.000641	CbGpPWpGaD
Telaprevir—CTSK—Immune System—CRP—chronic obstructive pulmonary disease	9.52e-05	0.000639	CbGpPWpGaD
Telaprevir—ALB—Platelet degranulation—SERPINE1—chronic obstructive pulmonary disease	9.45e-05	0.000634	CbGpPWpGaD
Telaprevir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	9.43e-05	0.000632	CbGpPWpGaD
Telaprevir—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	9.3e-05	0.000624	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	9.3e-05	0.000624	CbGpPWpGaD
Telaprevir—CTSS—Immune System—CD8A—chronic obstructive pulmonary disease	9.22e-05	0.000619	CbGpPWpGaD
Telaprevir—CTSK—Immune System—TLR4—chronic obstructive pulmonary disease	9.13e-05	0.000612	CbGpPWpGaD
Telaprevir—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—chronic obstructive pulmonary disease	9e-05	0.000604	CbGpPWpGaD
Telaprevir—ALB—Folate Metabolism—IL1B—chronic obstructive pulmonary disease	8.95e-05	0.000601	CbGpPWpGaD
Telaprevir—ALB—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	8.75e-05	0.000587	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	8.75e-05	0.000587	CbGpPWpGaD
Telaprevir—CTSS—Immune System—ERBB3—chronic obstructive pulmonary disease	8.58e-05	0.000575	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	8.31e-05	0.000558	CbGpPWpGaD
Telaprevir—ALB—Vitamin B12 Metabolism—TNF—chronic obstructive pulmonary disease	7.98e-05	0.000536	CbGpPWpGaD
Telaprevir—CTSS—Immune System—CRP—chronic obstructive pulmonary disease	7.84e-05	0.000526	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—EGFR—chronic obstructive pulmonary disease	7.77e-05	0.000521	CbGpPWpGaD
Telaprevir—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	7.64e-05	0.000513	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	7.55e-05	0.000507	CbGpPWpGaD
Telaprevir—CTSS—Immune System—TLR4—chronic obstructive pulmonary disease	7.52e-05	0.000504	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—EGFR—chronic obstructive pulmonary disease	7.46e-05	0.000501	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	7.27e-05	0.000488	CbGpPWpGaD
Telaprevir—ALB—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	7.11e-05	0.000477	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	7.08e-05	0.000475	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	6.79e-05	0.000456	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.76e-05	0.000453	CbGpPWpGaD
Telaprevir—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	6.72e-05	0.000451	CbGpPWpGaD
Telaprevir—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	6.65e-05	0.000446	CbGpPWpGaD
Telaprevir—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	6.64e-05	0.000446	CbGpPWpGaD
Telaprevir—ALB—Platelet degranulation—VEGFA—chronic obstructive pulmonary disease	6.5e-05	0.000436	CbGpPWpGaD
Telaprevir—ALB—Folate Metabolism—TNF—chronic obstructive pulmonary disease	6.5e-05	0.000436	CbGpPWpGaD
Telaprevir—ALB—Vitamin B12 Metabolism—IL6—chronic obstructive pulmonary disease	6.44e-05	0.000432	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—EGFR—chronic obstructive pulmonary disease	6.4e-05	0.000429	CbGpPWpGaD
Telaprevir—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—chronic obstructive pulmonary disease	6.19e-05	0.000415	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—EGFR—chronic obstructive pulmonary disease	6.15e-05	0.000412	CbGpPWpGaD
Telaprevir—ALB—Metabolism—APIP—chronic obstructive pulmonary disease	6.05e-05	0.000406	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—IL6—chronic obstructive pulmonary disease	5.97e-05	0.000401	CbGpPWpGaD
Telaprevir—ALB—Platelet degranulation—TGFB1—chronic obstructive pulmonary disease	5.96e-05	0.0004	CbGpPWpGaD
Telaprevir—CTSK—Immune System—IL1B—chronic obstructive pulmonary disease	5.94e-05	0.000399	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	5.75e-05	0.000386	CbGpPWpGaD
Telaprevir—ALB—Folate Metabolism—TP53—chronic obstructive pulmonary disease	5.73e-05	0.000384	CbGpPWpGaD
Telaprevir—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—chronic obstructive pulmonary disease	5.68e-05	0.000381	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	5.68e-05	0.000381	CbGpPWpGaD
Telaprevir—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	5.59e-05	0.000375	CbGpPWpGaD
Telaprevir—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	5.51e-05	0.00037	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.3e-05	0.000356	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	5.3e-05	0.000356	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	5.28e-05	0.000354	CbGpPWpGaD
Telaprevir—ALB—Folate Metabolism—IL6—chronic obstructive pulmonary disease	5.24e-05	0.000352	CbGpPWpGaD
Telaprevir—ALB—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	5.16e-05	0.000346	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.06e-05	0.00034	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	4.93e-05	0.000331	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—TGFB2—chronic obstructive pulmonary disease	4.92e-05	0.00033	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—IL6—chronic obstructive pulmonary disease	4.92e-05	0.00033	CbGpPWpGaD
Telaprevir—CTSS—Immune System—IL1B—chronic obstructive pulmonary disease	4.89e-05	0.000328	CbGpPWpGaD
Telaprevir—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.66e-05	0.000313	CbGpPWpGaD
Telaprevir—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.6e-05	0.000308	CbGpPWpGaD
Telaprevir—CTSK—Immune System—EGFR—chronic obstructive pulmonary disease	4.53e-05	0.000304	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.49e-05	0.000301	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—HDAC2—chronic obstructive pulmonary disease	4.42e-05	0.000296	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	4.31e-05	0.000289	CbGpPWpGaD
Telaprevir—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.28e-05	0.000287	CbGpPWpGaD
Telaprevir—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.22e-05	0.000283	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	4.19e-05	0.000281	CbGpPWpGaD
Telaprevir—ALB—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	4.16e-05	0.000279	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.06e-05	0.000273	CbGpPWpGaD
Telaprevir—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.06e-05	0.000272	CbGpPWpGaD
Telaprevir—ALB—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.01e-05	0.000269	CbGpPWpGaD
Telaprevir—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4e-05	0.000269	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—PLAUR—chronic obstructive pulmonary disease	3.98e-05	0.000267	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.97e-05	0.000267	CbGpPWpGaD
Telaprevir—ALB—Metabolism—GC—chronic obstructive pulmonary disease	3.9e-05	0.000262	CbGpPWpGaD
Telaprevir—CTSS—Immune System—EGFR—chronic obstructive pulmonary disease	3.73e-05	0.00025	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.65e-05	0.000245	CbGpPWpGaD
Telaprevir—ALB—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.62e-05	0.000243	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.51e-05	0.000236	CbGpPWpGaD
Telaprevir—CTSK—Immune System—IL6—chronic obstructive pulmonary disease	3.48e-05	0.000233	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	3.42e-05	0.000229	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.35e-05	0.000225	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.28e-05	0.00022	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	3.27e-05	0.000219	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.18e-05	0.000213	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.11e-05	0.000209	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.89e-05	0.000194	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	2.88e-05	0.000193	CbGpPWpGaD
Telaprevir—CTSS—Immune System—IL6—chronic obstructive pulmonary disease	2.86e-05	0.000192	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—MMP1—chronic obstructive pulmonary disease	2.85e-05	0.000191	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	2.84e-05	0.00019	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—PLAU—chronic obstructive pulmonary disease	2.79e-05	0.000187	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.76e-05	0.000185	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.72e-05	0.000183	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	2.65e-05	0.000177	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	2.61e-05	0.000175	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—NOS2—chronic obstructive pulmonary disease	2.57e-05	0.000172	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	2.55e-05	0.000171	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.52e-05	0.000169	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	2.43e-05	0.000163	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.16e-05	0.000145	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	2.16e-05	0.000145	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	2.14e-05	0.000144	CbGpPWpGaD
Telaprevir—ALB—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.13e-05	0.000143	CbGpPWpGaD
Telaprevir—ALB—Metabolism—GCLC—chronic obstructive pulmonary disease	2.11e-05	0.000141	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	2.1e-05	0.000141	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—NOS3—chronic obstructive pulmonary disease	2.06e-05	0.000138	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.96e-05	0.000131	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CTGF—chronic obstructive pulmonary disease	1.92e-05	0.000129	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.87e-05	0.000125	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.84e-05	0.000124	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.77e-05	0.000119	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.68e-05	0.000113	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.64e-05	0.00011	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.55e-05	0.000104	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—VEGFA—chronic obstructive pulmonary disease	1.49e-05	9.97e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.48e-05	9.9e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.46e-05	9.77e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—TGFB1—chronic obstructive pulmonary disease	1.36e-05	9.15e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.36e-05	9.1e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.29e-05	8.68e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.29e-05	8.63e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.28e-05	8.56e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.19e-05	7.97e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.15e-05	7.71e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.14e-05	7.62e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.13e-05	7.56e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—TP53—chronic obstructive pulmonary disease	1.12e-05	7.53e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.04e-05	6.96e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.56e-06	6.41e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—NOS3—chronic obstructive pulmonary disease	8.36e-06	5.61e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.97e-06	5.35e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.86e-06	5.27e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	7.66e-06	5.14e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	7.33e-06	4.92e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.32e-06	4.91e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.94e-06	4.66e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	4.72e-06	3.17e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	4.51e-06	3.03e-05	CbGpPWpGaD
